Hospital
Mid-Valley Healthcare INC
Mid-Valley Healthcare INC was paid $34.47M by Medicaid between Jan 2018 and Dec 2024, across 101 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoMID-VALLEY HEALTHCARE INC
LEBANON, OR 97355
LEBANON, OR 97355
33aNPI1689625980assigned 05/12/2006
33bProvider typeCritical Access Hospital
28Total paid$34.47M
24GClaims402,169
24DCodes billed101
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Oregon
Rank by total paid#1 of 22
Median peer was paid$3.52M
This provider vs. median9.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,521 | $3.86M | |
| 2019 | 52,991 | $4.22M | |
| 2020 | 45,773 | $3.56M | |
| 2021 | 64,300 | $5.27M | |
| 2022 | 64,400 | $5.74M | |
| 2023 | 59,312 | $5.86M | |
| 2024incomplete | 59,872 | $5.95M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 41,799 | 26,806 | $10.30M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 44,029 | 28,825 | $7.32M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 17,773 | 10,957 | $4.83M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.4% | 2,311 | 2,125 | $1.86M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.9% | 18,911 | 13,931 | $1.67M |
| 80053 | Comprehensive metabolic panel | 3.1% | 45,243 | 39,656 | $1.06M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 37,373 | 32,303 | $696K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.9% | 9,191 | 8,312 | $665K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 12,281 | 10,337 | $663K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 1.4% | 106 | 84 | $492K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.4% | 4,812 | 4,318 | $476K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 7,545 | 6,486 | $430K |
89 more codes
| 71045 | Radiologic examination, chest; single view | 1.1% | 6,556 | $387K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 7,931 | $310K |
| 36415 | Collection of venous blood by venipuncture | <1% | 39,188 | $295K |
| 81001 | <1% | 21,329 | $286K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 808 | $219K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,823 | $203K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,838 | $200K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,734 | $154K |
| 84484 | <1% | 5,312 | $148K | |
| 83690 | <1% | 5,771 | $122K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,308 | $120K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,880 | $116K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,460 | $98K |
| 80306 | <1% | 2,075 | $96K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,128 | $95K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,284 | $94K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,556 | $90K |
| 80061 | Lipid panel | <1% | 4,112 | $87K |
| 85027 | <1% | 6,481 | $82K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 13 | $71K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,361 | $69K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 944 | $66K |
| 83735 | <1% | 3,939 | $55K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,506 | $49K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,696 | $46K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 800 | $33K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 977 | $30K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 776 | $29K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 241 | $29K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 3,992 | $29K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 834 | $28K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 23 | $20K |
| 81025 | <1% | 838 | $17K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 21 | $16K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 174 | $15K |
| 83605 | <1% | 681 | $14K | |
| 82607 | <1% | 427 | $13K | |
| 59025 | Fetal non-stress test | <1% | 156 | $13K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 15 | $12K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 168 | $12K |
| 97602 | <1% | 156 | $11K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 324 | $10K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 106 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 705 | $9K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 248 | $8K |
| 73630 | <1% | 42 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,264 | $6K |
| 84703 | <1% | 143 | $4K | |
| 86780 | <1% | 280 | $4K | |
| 85610 | <1% | 524 | $4K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 154 | $4K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 90 | $4K |
| 82803 | <1% | 50 | $4K | |
| 84145 | <1% | 131 | $3K | |
| 96376 | <1% | 52 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 53 | $3K |
| 87040 | <1% | 64 | $3K | |
| 86803 | <1% | 127 | $3K | |
| A9270 | Non-covered item or service | <1% | 3,315 | $3K |
| 86140 | <1% | 307 | $3K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 89 | $2K |
| 84439 | <1% | 157 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $2K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14 | $2K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 44 | $2K |
| 76830 | Ultrasound, transvaginal | <1% | 12 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 101 | $2K |
| 97597 | <1% | 22 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 29 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 29 | $1K |
| 87800 | <1% | 40 | $1K | |
| 85652 | <1% | 137 | $1K | |
| 82948 | <1% | 177 | $1K | |
| 73030 | <1% | 14 | $1K | |
| 83550 | <1% | 51 | $1K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 43 | $1K |
| 86850 | <1% | 27 | $1K | |
| 88142 | <1% | 29 | $839.00 | |
| 82728 | <1% | 53 | $747.76 | |
| 87077 | <1% | 74 | $739.32 | |
| 83880 | <1% | 33 | $681.46 | |
| 83540 | <1% | 51 | $641.33 | |
| 99223 | Prolong inpt eval add15 m | <1% | 16 | $559.74 |
| 85379 | <1% | 38 | $385.10 | |
| 82746 | <1% | 32 | $381.60 | |
| 82550 | <1% | 27 | $360.83 | |
| 80069 | <1% | 114 | $261.38 | |
| 99441 | <1% | 21 | $144.75 | |
| 87186 | <1% | 18 | $128.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRACKHAM, DANIEL (CEO-SLCH)
| Provider | Location | Paid |
|---|---|---|
| Albany General Hospital | Albany, OR | $4.53M |
| Mid-Valley Healthcare, INC. | Sweet Home, OR | $3.03M |
| Mid-Valley Healthcare, INC. | Lebanon, OR | $2.55M |
| Mid-Valley Healthcare, INC. | Lebanon, OR | $1.11M |
| Mid-Valley Healthcare, INC. | Lebanon, OR | $925K |
| Albany General Hospital | Albany, OR | $825K |
| Mid-Valley Healthcare, INC. | Lebanon, OR | $766K |
| Albany General Hospital | Albany, OR | $612K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.